Workshop I: Parkinson's disease and sleep--results of the group discussion

The group agreed on the facts that unwanted sleep onset has been observed after non-ergot as well as ergot dopamine agonists, that patients on these drugs need to be warned, that patients who have experienced sleepiness already must not drive a car unless the dosage is lowered and sleepiness has van...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neurology 2000-09, Vol.247 Suppl 4 (S4), p.IV/34-IV35
Main Authors: Clarenbach, P, Greulich, W, Meinck, H M, Rathey, B, Schipper, H, Lachenmayer, L, Werner, M
Format: Article
Language:English
Subjects:
Causality
Clinical Protocols - standards
Dopamine Agents - adverse effects
Education
Humans
Parkinson Disease - complications
Parkinson Disease - drug therapy
Parkinson's disease
Patient Selection
Sleep Wake Disorders - chemically induced
Sleep Wake Disorders - classification
Sleep Wake Disorders - physiopathology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The group agreed on the facts that unwanted sleep onset has been observed after non-ergot as well as ergot dopamine agonists, that patients on these drugs need to be warned, that patients who have experienced sleepiness already must not drive a car unless the dosage is lowered and sleepiness has vanished, that a genetic predisposition for narcoleptic cataplexy has to be ruled out, that predictors of so-called sleep attacks need to be explored individually with the help of sleepiness scales and collectively in a careful study, respectively.
ISSN:0340-5354
1432-1459
DOI:10.1007/PL00007773